140 related articles for article (PubMed ID: 31461916)
1. Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer's Disease.
Higginbotham L; Dammer EB; Duong DM; Modeste E; Montine TJ; Lah JJ; Levey AI; Seyfried NT
Proteomes; 2019 Aug; 7(3):. PubMed ID: 31461916
[TBL] [Abstract][Full Text] [Related]
2. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
[TBL] [Abstract][Full Text] [Related]
3. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
[TBL] [Abstract][Full Text] [Related]
4. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried NT; Dammer EB; Swarup V; Nandakumar D; Duong DM; Yin L; Deng Q; Nguyen T; Hales CM; Wingo T; Glass J; Gearing M; Thambisetty M; Troncoso JC; Geschwind DH; Lah JJ; Levey AI
Cell Syst; 2017 Jan; 4(1):60-72.e4. PubMed ID: 27989508
[TBL] [Abstract][Full Text] [Related]
5. Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease.
Guo Q; Dammer EB; Zhou M; Kundinger SR; Gearing M; Lah JJ; Levey AI; Shulman JM; Seyfried NT
Front Mol Neurosci; 2021; 14():623659. PubMed ID: 33815056
[TBL] [Abstract][Full Text] [Related]
6. Effects of
Dai J; Johnson ECB; Dammer EB; Duong DM; Gearing M; Lah JJ; Levey AI; Wingo TS; Seyfried NT
Front Mol Neurosci; 2018; 11():454. PubMed ID: 30618606
[TBL] [Abstract][Full Text] [Related]
7. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
8. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
[TBL] [Abstract][Full Text] [Related]
9. Genetic background influences the 5XFAD Alzheimer's disease mouse model brain proteome.
Hurst CD; Dunn AR; Dammer EB; Duong DM; Shapley SM; Seyfried NT; Kaczorowski CC; Johnson ECB
Front Aging Neurosci; 2023; 15():1239116. PubMed ID: 37901791
[TBL] [Abstract][Full Text] [Related]
10. Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.
Johnson ECB; Carter EK; Dammer EB; Duong DM; Gerasimov ES; Liu Y; Liu J; Betarbet R; Ping L; Yin L; Serrano GE; Beach TG; Peng J; De Jager PL; Haroutunian V; Zhang B; Gaiteri C; Bennett DA; Gearing M; Wingo TS; Wingo AP; Lah JJ; Levey AI; Seyfried NT
Nat Neurosci; 2022 Feb; 25(2):213-225. PubMed ID: 35115731
[TBL] [Abstract][Full Text] [Related]
11. Genetic background influences the 5XFAD Alzheimer's disease mouse model brain proteome.
Hurst CD; Dunn AR; Dammer EB; Duong DM; Seyfried NT; Kaczorowski CC; Johnson ECB
bioRxiv; 2023 Jun; ():. PubMed ID: 37398142
[TBL] [Abstract][Full Text] [Related]
12. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
13. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
[TBL] [Abstract][Full Text] [Related]
14. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
15. Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.
Tandon R; Levey AI; Lah JJ; Seyfried NT; Mitchell CS
J Alzheimers Dis; 2023; 92(2):411-424. PubMed ID: 36776048
[TBL] [Abstract][Full Text] [Related]
16. Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.
Donovan LE; Dammer EB; Duong DM; Hanfelt JJ; Levey AI; Seyfried NT; Lah JJ
Alzheimers Res Ther; 2013; 5(3):32. PubMed ID: 23764030
[TBL] [Abstract][Full Text] [Related]
17. Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation.
Kandigian SE; Ethier EC; Kitchen RR; Lam TT; Arnold SE; Carlyle BC
Brain Commun; 2022; 4(3):fcac103. PubMed ID: 35611312
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive transcript-level analysis reveals transcriptional reprogramming during the progression of Alzheimer's disease.
Wu H; Wang J; Hu X; Zhuang C; Zhou J; Wu P; Li S; Zhao RC
Front Aging Neurosci; 2023; 15():1191680. PubMed ID: 37396652
[TBL] [Abstract][Full Text] [Related]
19. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
20. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
